Did You Know...
...During the Civil War, the Confederacy established its own Patent Office which issued 266 patents, a third of which concerned implements of war.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8158680 | Ester of hexyldecanol having short-chained fatty acids The present invention relates to the use of one or more esters of 2-hexyldeconal having fatty acids of the general formula (I) R1-COOH, wherein R1 is a linear or branched, saturated or unsaturated alkyl radical having 1 to 6 carbon atoms, in and/or for the productio... | 04/17/2012 |
| 8106093 | Glycogen or polysaccharide storage disease treatment method A method for treating glycogen storage disease by administering an effective amount of a composition that includes ketogenic odd carbon fatty acids that ameliorate the symptoms of these diseases. ... | 01/31/2012 |
| 7994219 | Approach to anti-microbial host defense with molecular shields with lipoxin compounds Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. The BPI inducing agents include, for example, lipoxin compounds. ... | 08/09/2011 |
| 7915311 | Approach to anti-microbial host defense with molecular shields with lipoxin compounds Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. The BPI inducing agents include, for example, lipoxin compounds. ... | 03/29/2011 |
| 7807717 | Pesticide for insect control A method for the control of insects breeding on water surfaces and particularly mosquitoes, comprising blending in a high shear mixer water, the ester of a fatty acid of 10 to 25 carbon atoms and a low molecular weight alcohol, such as methanol or ethanol, an emulsi... | 10/05/2010 |
| 7645795 | Method for treating amyotrophic lateral sclerosis The administration of nutritional supplements such as phosphatidylcholine; linoleic acid and alpha linolenic acid in an approximately 4:1 (v/v) ratio; and mineral supplements provides an effective method for the treatment of ALS. Subjects presenting with symptoms in... | 01/12/2010 |
| 7569607 | Spider esters in personal care applications The present invention is drawn to a process for providing emolliency to the skin using a series so called “spider esters”. These esters are derived from poly-hydroxy functional compounds sequentially reacted with ethylene oxide or propylene oxide, followed by th... | 08/04/2009 |
| 7473707 | Spider esters in personal care applications The present invention is drawn to a process for providing emolliency to the skin using a series so called “spider esters”. These esters are derived from poly-hydroxy functional compounds sequentially reacted with ethylene oxide or propylene oxide, followed by th... | 01/06/2009 |
| 7414075 | Composition for lowering internal lipid content A composition for lowering internal lipid in a subject which contains a capsinoid substance represented by the following formula wherein n is an integer from 0 to 10. Methods of using the compositions are disclosed and incl... | 08/19/2008 |
| 7399755 | Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same The invention is directed to formulations comprised of multiple dietary and endogenously made antioxidants and B-vitamins and the use of these formulations in preventing and treating coronary artery disease. ... | 07/15/2008 |
| 7378443 | Fatty acid analogues for the treatment of cancer A fatty acid analogue of the general formula: R1-[xi-CH2]n—COOR2, wherein R1 is: a C2-C24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C | 05/27/2008 |
| 7368435 | Topical endoparasiticide and ectoparasiticide formulations A topical formulation having significant parasiticidal activity effective against endoparasites and/or ectoparasites such as heartworms, mites, fleas, ticks, flies is provided, which can be safe to use and avoids the many common deleterious side effects of conventio... | 05/06/2008 |
| 7351424 | Enhanced purity trans-lutein-ester compositions and methods of making same The present invention relates a composition having a high content of xanthophyll esters, where the xanthophyll ester component of the composition is comprised of a high proportion of trans-lutein esters. The present invention also provides methods of making and usin... | 04/01/2008 |
| 7345092 | High concentration topical insecticides containing pyrethroids A topical insecticide preparation is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. The topical insecticide contains a combination of a first pyrethroid insecticide effective for killing fleas,... | 03/18/2008 |
| 7332152 | Cosmetic composition A cosmetic composition is provided comprising vitamin B6, vitamin B3 and an organic acid. The components of the composition interact synergistically to enhance skin lightening. ... | 02/19/2008 |
| 7316810 | Foaming composition for washing and treating hair and/or scalp based on an active principle The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least... | 01/08/2008 |
| 7291323 | Silicone lubricating and conditioning compositions The invention is directed to compositions that provide outstanding lubrication and conditioning to fibers. Key to the invention is the realization that the there must be (a) an alkoxylated silicone compound, and (b) a specific mono functional ester made from a cappe... | 11/06/2007 |
| 7259295 | PUFA polyketide synthase systems and uses thereof The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems isolated from or derived from non-bacterial organisms, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding bi... | 08/21/2007 |
| 7256022 | Pufa polyketide synthase systems and uses thereof The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems isolated from or derived from non-bacterial organisms, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding bi... | 08/14/2007 |
| 7256023 | PUFA polyketide synthase systems and uses thereof The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems isolated from or derived from non-bacterial organisms, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding bi... | 08/14/2007 |
| 7247461 | Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems isolated from or derived from Schizochytrium sp., to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding ... | 07/24/2007 |
| 7235576 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy. ... | 06/26/2007 |
| 7223798 | Lipoxin Aanalogs This invention is directed to lipoxin A4 analogs of the following formula (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are ... | 05/29/2007 |
| 7217856 | PUFA polyketide synthase systems and uses thereof Disclosed are the complete polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from the bacterial microorganisms Shewanella japonica and Shewanella olleyana, and biologically active fragments and homologues thereof. More particularly, t... | 05/15/2007 |
| 7214853 | Schizochytrium PKS genes The present invention relates to compositions and methods for preparing poly-unsaturated long chain fatty acids in plants, plant parts and plant cells, such as leaves, roots, fruits and seeds. Nucleic acid sequences and constructs encoding PKS-like genes required fo... | 05/08/2007 |
| 7211418 | PUFA polyketide synthase systems and uses thereof The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding biologically active domains of such a PUFA PKS system, t... | 05/01/2007 |
| 7202276 | Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia This invention relates to the regulation of vascular endothelium biocompatibility and to the inhibition of vessel wall cell and other types of cell hyperplasia following vessel wall dysfunction and/or injury. More particularly, the invention relates to the dietetic ... | 04/10/2007 |
| 7199151 | DHA-pharmaceutical agent conjugates of taxanes The invention provides conjugates of cis-docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided. ... | 04/03/2007 |
| 7179475 | Anhydrous topical skin preparations The present invention provides anhydrous compositions for topical delivery of a medicament comprising (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from ... | 02/20/2007 |
| 7163960 | Treatment and prevention of inflammatory disorders The invention relates to methods of treating and preventing disorders associated with elevated TNF-α and/or IL-1β by administering therapeutic amounts of stearidonic acid. Further provided are methods for down-regulating TNF-α and/or IL-1β and assays for determi... | 01/16/2007 |
| 7157110 | Fat compositions Fat compositions that contain a vegetable oil and a plant-derived wax component are described. Food and cosmetic products containing such fat compositions also are described. ... | 01/02/2007 |
| 7157496 | Prophylactic agent of hypertension containing a conjugated fatty acid as an effective ingredient and the use thereof The objects of this invention are to prevent or ameliorate hypertension to improve physical constitution and finally to provide feeds, drinks, foods, health food supplements and pharmaceuticals which may be led to the prophylaxis or amelioration of life style relate... | 01/02/2007 |
| 7132451 | Inhibition of TNF-α-initiated neutrophil response The impact of lipoxin A4 (LXA4) and aspirin-triggered-lipoxins (ATL) was investigated in tumor necrosis factor (TNFα)-initiated neutrophil (PMN) responses in vitro and in vivo using metabolically stable LX analogs. At concentrations as low as ... | 11/07/2006 |
| 7118735 | Cosmetic composition Disclosed herein is a composition, for example, a cosmetic care and/or makeup composition for a keratin material, comprising, in a cosmetically acceptable medium, i) at least one polyester resulting from esterification of at least one Guerbet capped polyester ii) at... | 10/10/2006 |
| 7109241 | Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof Antimicrobial compositions containing a carboxylic acid, for example, a fatty acid, and a carrier medium including a freezing point depressant are disclosed. The compositions can be formulated for use as a teat dip, for use on milk producing animals. In one particul... | 09/19/2006 |
| 7098246 | Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wher... | 08/29/2006 |
| 7090016 | Well having inhibited microbial growth The invention includes methods of inhibiting microbial growth in a well. A packing material containing a mixture of a first material and an antimicrobial agent is provided to at least partially fill a well bore. One or more access tubes are provided in an annular sp... | 08/15/2006 |
| 7084118 | Combination treatment with t-PA variant and low molecular weight heparin The invention concerns an improved therapeutic regimen for the treatment of thrombolytic disorders, such as acute myocardial infarction (AMI). In particular, the present invention concerns the treatment of thrombolytic disorders, e.g. AMI, with a combination of a ti... | 08/01/2006 |
| 7041840 | Antioxidant triacylglycerols and lipid compositions A lipid composition includes triacylglycerols that include unsaturated fatty acids such as alpha linolenic acid and antioxidant moeities such as pyruvic acid. ... | 05/09/2006 |
| 7038005 | Guerbet capped polyesters The present invention is related to a series of polyesters based upon the reaction of succinic acid, dimer alcohol and Guerbet alcohol. The resulting polyester is a high molecular weight product that is well tolerated by the skin and has outstanding emolliency. The ... | 05/02/2006 |
